title: Treatment outcomes in stage IIIA non-small-cell lung cancer in a community cancer center.
abstract: BACKGROUND
  Treatment outcomes for non-small-cell lung cancer (NSCLC) patients diagnosed at stage IIIA have been analyzed in many studies, which generally involve patients younger and healthier than the average patient with this disease.
  
  
  OBJECTIVE
  To analyze demographics and treatment outcomes in patients with stage IIIA NSCLC at a community cancer center.
  
  
  METHODS
  We reviewed charts of 226 patients diagnosed with stage IIIA NSCLC from January 2003 to December 2008 treated at our community cancer center. Results Median overall survival for all patients and sequentially and concurrently treated chemoradiation patients were 18 months, and 18 months, and 20 months, respectively. Median overall survival for women and men was 24 months and 16 months, respectively.
  
  
  RESULTS
  Median overall survival for all patients and sequentially and concurrently treated chemoradiation patients were 18 months, and 18 months, and 20 months, respectively. Median overall survival for women and men was 24 months and 16 months, respectively.
  
  
  CONCLUSIONS
  Study design was retrospective and some medical records were not available. However, this population is likely representative of patients treated in similar settings.
  
  
  CONCLUSIONS
  In our population, advanced age and male gender were associated with lower median survival. Responses to concurrent and sequential chemoradiation seemed to differ based on age group, which may be useful as a prognostic guideline for similar populations.
authors: Department of Internal Medicine, Christiana Care Health System, Newark, Delaware, USA.
authors: Shaun
authors: S
authors: Hanson
authors: Department of Internal Medicine, Christiana Care Health System, Newark, Delaware, USA.
authors: Kamleish
authors: K
authors: Persad
authors: Department of Internal Medicine, Christiana Care Health System, Newark, Delaware, USA.
authors: Xian
authors: X
authors: Qiao
authors: Helen F Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, Delaware, USA.
authors: Michael
authors: M
authors: Guarino
authors: Helen F Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, Delaware, USA. npetrelli@christianacare.org.
authors: Nicholas
authors: N
authors: Petrelli
keywords: cancer; concomitant; lung; sequential; stage III